In-hospital testing of NIVPredict - an AI tool for early prediction of non-invasive ventilation outcome in acute respiratory failure

Read full text Summarise with VIRAT
Authors: Hang Yu, Sina Saffaran, Abdisamad Ali, Catherine Henry, Naveed Mustfa, Ajit Thomas, Ashwin Rajhan, Sannaan Isrhad, Liam Weaver, Roberto Tonelli, Luca Salvatore Menga, Qing Zhang
+14 more Moein E. Samadi, Andreas Schuppert, J Laffey, Luigi Camporota, Antonio M. Esquinas, Domenico L. Grieco, Massimo Antonelli, Lucas Martins de Lima, Leticia Barbosa Kawano-Dourado, Israel Silva Maia, Alexandre Biasi Cavalcanti, Enrico Maria Clini, Timothy E. Scott, Declan Bates
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background Successful non-invasive ventilation (NIV) reduces ICU length of stay, the need for intubation and the risk of death. However, patients who fail NIV and require intubation have a higher risk of death. We developed NIVPredict, an easy-to-use web-based AI tool to predict NIV outcome within two hours of initiation in patients with acute respiratory failure (ARF) from diverse aetiologies and tested its useability in a hospital setting. Methods This study included data from immunocompromised and immunocompetent patients with hypoxemic ARF due to pneumonia, sepsis or COVID-19, and hypercapnic ARF due to acute exacerbation of chronic obstructive pulmonary disease or obesity hypoventilation syndrome. The tool uses the recently proposed Tabular Prior-Data Fitted Network (TabPFN) machine learning model and was trained using a dataset of routinely collected measurements taken within one hour after NIV initiation in 665 ARF patients from the recent RENOVATE trial in Brazil. Initial external validation of the model was conducted on a dataset of 422 ARF patients from Italy, Spain, and the USA. Subsequently, the useability of a web-based tool based on the model was tested by clinicians at the University Hospitals of North Midlands NHS Trust in the UK between December 2024 and November 2025, who applied it to data collected from 57 eligible ARF patients. Results The AI tool provided accurate and robust prediction of NIV outcomes and consistently outperformed conventional clinical indices across all validation settings. In internal repeated cross-validation, external validation, and in-hospital testing, the tool achieved AUCs of 0.793, 0.772, and 0.858, vs. 0.717, 0.709, and 0.693 for the best clinical index (Updated HACOR score), and balanced accuracies of 78.9%, 74.5%, and 85.0%, vs. 68.7%, 63.7%, and 67.6% for the best clinical index (HACOR or Updated HACOR score), respectively. Conclusions This study demonstrates superior predictive performance, compared to current clinical indices, of an AI-based tool for NIV outcome prediction on a cohort of patients with overt-acute and acute-on-chronic respiratory failure. Clinical useability of the tool was confirmed via testing by clinicians in a hospital setting, motivating its future evaluation in prospective multi-centre studies.

Fields of Study & Subjects

Respiratory Support and Mechanisms Obstructive Sleep Apnea Research Neonatal Respiratory Health Research

Publication details

Journal / source
Figshare
Publication date
15 February 2026
Language
EN